Based on the provided information, there is no specific mention of the risks of live vaccines on Cosentyx (secukinumab) [1][2]. However, the National Center for Biotechnology Information (NCBI) states that "the use of biologic agents during the COVID-19 pandemic should be individualized and balanced against the risk of disease worsening" [3].

It is generally recommended that individuals on biologic therapies, like Cosentyx, should avoid live vaccines due to the potential risk of infection [3]. This is because biologic therapies like Cosentyx work by suppressing the immune system, which can increase the risk of infection and reduce the effectiveness of vaccines [3].

Therefore, while there is no specific information on the risks of live vaccines on Cosentyx, it is advisable for individuals on this medication to consult with their healthcare provider before receiving any vaccinations, including live vaccines [3].

Sources:
[1] <https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX>
[2] <https://www.cosentyx.com/all/covid19>
[3] <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767096/>